Rofecoxib inhibits heterotopic ossification after total hip arthroplasty

Archives of Orthopaedic and Trauma Surgery

Volumn 127, Issue 7, 2007, Pages 557-561

  van der Heide, Huub J L ^a   Koorevaar, Rinco C T ^a   Lemmens, J Albert M ^a   van Kampen, Albert ^a   Schreurs, Willem B ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Arthroplasty; COX 2; Heterotopic ossification; Hip; Rofecoxib

Indexed keywords

ANTIBIOTIC AGENT; CEFAZOLIN; CIMETIDINE; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; NADROPARIN; NONSTEROID ANTIINFLAMMATORY AGENT; OMEPRAZOLE; PANTOPRAZOLE; PARACETAMOL; RANITIDINE; ROFECOXIB; TRAMADOL;

ADULT; AGED; ARTICLE; BONE RADIOGRAPHY; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DIGESTIVE SYSTEM PERFORATION; DRUG WITHDRAWAL; FEMALE; GASTROINTESTINAL HEMORRHAGE; GASTROINTESTINAL SYMPTOM; HEARTBURN; HETEROTOPIC OSSIFICATION; HIP DISLOCATION; HIP OSTEOARTHRITIS; HUMAN; LUNG EMBOLISM; MALE; NAUSEA; OSSIFICATION; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; TOTAL HIP PROSTHESIS; WOUND INFECTION;

ADULT; AGED; AGED, 80 AND OVER; ARTHROPLASTY, REPLACEMENT, HIP; CYCLOOXYGENASE 2 INHIBITORS; FEMALE; FOLLOW-UP STUDIES; HUMANS; LACTONES; MALE; MIDDLE AGED; OSSIFICATION, HETEROTOPIC; PROSPECTIVE STUDIES; RESEARCH DESIGN; SULFONES;

EID: 34547802265     PISSN: 09368051     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00402-006-0243-1     Document Type: Article

References (26)

1. Neal BC, Rodgers A, Clark T et al (2000) A systematic survey of 13 randomized trials of non-steroidal anti-inflammatory drugs for the prevention of heterotopic bone formation after major hip surgery. Acta Orthop Scand 71:122-128
2. Dorn U, Grethen C, Effenberger H, Berka H, Ramsauer T, Drekonja T (1998) Indomethacin for prevention of heterotopic ossification after hip arthroplasty. A randomized comparison between 4 and 8 days of treatment. Acta Orthop Scand 69:107-110
3. Gebuhr P, Soelberg M, Orsnes T, Wilbek H (1991) Naproxen prevention of heterotopic ossification after hip arthroplasty. A prospective control study of 55 patients. Acta Orthop Scand 62:226-229
4. Kjaersgaard-Andersen P, Schmidt SA (1986) Indomethacin for prevention of ectopic ossification after hip arthroplasty. Acta Orthop Scand 57:12-14
5. Knelles D, Barthel T, Karrer A, Kraus U, Eulert J, Kolbl O (1997) Prevention of heterotopic ossification after total hip replacement. A prospective, randomised study using acetylsalicylic acid, indomethacin and fractional or single-dose irradiation. J Bone Joint Surg Br 79:596-602
6. Wurnig C, Auersperg V, Boehler N et al (1997) Short term prophylaxis against heterotopic bone after cementless hip replacement. Clin Orthop 334:175-183
7. Cella JP, Salvati EA, Sculco TP (1988) Indomethacin for the prevention of heterotopic ossification following total hip arthroplasty. Effectiveness, contraindications, and adverse effects. J Arthroplasty 3:229-234
8. Bombardier C, Laine L, Reicin A et al (2000) Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. N Engl J Med 343:1520-1528, 2 p
9. Silverstein FE, Faich G, Goldstein JL et al (2000) Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthriAis and rheumatoid arthritis: The CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety Study. JAMA 284:1247-1255
10. Simon R (1989) Optimal two stage designs for phase ll clinical trials. Control Clin Trials 10:1-10
11. van der Heide HJ, Koorevaar RT, Schreurs BW, van Kampen A, Lemmens A (1999) Indomethacin for 3 days is not effective as prophylaxis for heterotopic ossification after primary total hip arthroplasty. J Arthroplasty 14:796-799
12. Brooker AF, Bowerman JW, Robinson RA, Riley LH Jr (1973) Ectopic ossification following total hip replacement. Incidence and a method of classification. J Bone Joint Surg Am 55:1629-1632
13. Barthel T, Baumann B, Noth U, Eulert J (2002) Prophylaxis of heterotopic ossification after total hip arthroplasty: A prospective randomized study comparing indomethacin and meloxicam. Acta Orthop Scand 73:611-614
14. Legenstein R, Bosch P, Ungersbock A (2003) Indomethacin versus meloxicam for prevention of heterotopic ossification after total hip arthroplasty. Arch Orthop Trauma Surg 123:91-94
15. van der Heide HJ, Spruit M, Slappendel R, Klooster N, van Limbeek J (2004) Prophylaxis for heterotopic ossification after primary total hip arthroplasty. A cohort study between indomethacin and meloxicam. Acta Orthop Belg 70:240-246
16. Romano CL, Duci D, Romano D, Mazza M, Meani E (2004) Celecoxib versus indomethacin in the prevention of heterotopic ossification after total hip arthroplasty. J Arthroplasty 19:14-18
17. Banovac K, Williams JM, Patrick LD, Levi A (2004) Prevention of heterotopic ossification after spinal cord injury with COX-2 selective inhibitor (rofecoxib). Spinal Cord 42:707-710
18. Feldman M, McMahon AT (2000) Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity? Ann Intern Med 132:134-143
19. Laine L (2002) The gastrointestinal effects of nonselective NSAIDs and COX-2-selective inhibitors. Semin Arthritis Rheum 32:25-32
20. Weber EWG, Slappendel R, Durieux ME, Dirksen R, van der Heide HJ, Spruit M (2003) COX 2 selectivity of non-steroidal anti-inflammatory drugs and perioperative blood loss in hip surgery. A randomized comparison of indomethacin and meloxicam. Eur J Anaesthesiologie 20:963-966
21. Ro J, Sudmann E, Marton PF (1976) Effect of indomethacin on fracture healing in rats. Acta Orthop Scand 47:588-599
22. Goodman S, Ma T, Trindade M et al (2002) COX-2 selective NSAID decreases bone ingrowth in vivo. J Orthop Res 20:1164-1169
23. Goodman SB, Ma T, Genovese M, Lane SR (2003) COX-2 selective inhibitors and bone. Int J Immunopathol Pharmacol 16:201-205
24. Harder AT, An YH (2003) The mechanisms of the inhibitory effects of nonsteroidal anti-inflammatory drugs on bone healing: A concise review. J Clin Pharmacol 43:807-815
25. Aspenberg P (2005) Drugs and fracture repair. Acta Orthop 76:741-748
26. Aspenberg P (2005) Postoperative Cox inhibitors and late prosthetic loosening-suspicion increases! Acta Orthop 76:733-734